nodes	percent_of_prediction	percent_of_DWPC	metapath
Bosentan—ABCB11—Paclitaxel—lung cancer	0.118	0.207	CbGbCtD
Bosentan—ABCB11—Vinblastine—lung cancer	0.104	0.181	CbGbCtD
Bosentan—ABCB11—Doxorubicin—lung cancer	0.0637	0.111	CbGbCtD
Bosentan—CYP2C9—Gefitinib—lung cancer	0.0386	0.0674	CbGbCtD
Bosentan—CYP2C9—Teniposide—lung cancer	0.0374	0.0654	CbGbCtD
Bosentan—CYP3A4—Topotecan—lung cancer	0.0245	0.0429	CbGbCtD
Bosentan—CYP3A4—Gefitinib—lung cancer	0.0224	0.0392	CbGbCtD
Bosentan—CYP3A4—Teniposide—lung cancer	0.0218	0.038	CbGbCtD
Bosentan—CYP2C9—Paclitaxel—lung cancer	0.0209	0.0365	CbGbCtD
Bosentan—CYP3A4—Vinorelbine—lung cancer	0.0173	0.0302	CbGbCtD
Bosentan—CYP2C9—Cisplatin—lung cancer	0.0168	0.0294	CbGbCtD
Bosentan—CYP3A4—Crizotinib—lung cancer	0.0137	0.024	CbGbCtD
Bosentan—CYP3A4—Erlotinib—lung cancer	0.0133	0.0232	CbGbCtD
Bosentan—CYP3A4—Paclitaxel—lung cancer	0.0121	0.0212	CbGbCtD
Bosentan—CYP3A4—Irinotecan—lung cancer	0.012	0.0209	CbGbCtD
Bosentan—CYP3A4—Vinblastine—lung cancer	0.0106	0.0186	CbGbCtD
Bosentan—CYP3A4—Etoposide—lung cancer	0.00959	0.0168	CbGbCtD
Bosentan—CYP3A4—Docetaxel—lung cancer	0.00878	0.0153	CbGbCtD
Bosentan—CYP3A4—Doxorubicin—lung cancer	0.00654	0.0114	CbGbCtD
Bosentan—EDNRB—mammary gland—lung cancer	0.00532	0.184	CbGeAlD
Bosentan—EDNRA—mammary gland—lung cancer	0.0044	0.152	CbGeAlD
Bosentan—EDNRB—bronchus—lung cancer	0.00292	0.101	CbGeAlD
Bosentan—EDNRB—cardiac atrium—lung cancer	0.00246	0.085	CbGeAlD
Bosentan—EDNRA—bronchus—lung cancer	0.00241	0.0833	CbGeAlD
Bosentan—EDNRA—trachea—lung cancer	0.00217	0.0748	CbGeAlD
Bosentan—EDNRA—cardiac atrium—lung cancer	0.00204	0.0703	CbGeAlD
Bosentan—EDNRB—lung—lung cancer	0.00188	0.065	CbGeAlD
Bosentan—EDNRA—lung—lung cancer	0.00156	0.0537	CbGeAlD
Bosentan—CYP2C9—mammary gland—lung cancer	0.00146	0.0502	CbGeAlD
Bosentan—EDNRB—lymph node—lung cancer	0.00129	0.0445	CbGeAlD
Bosentan—EDNRA—lymph node—lung cancer	0.00106	0.0368	CbGeAlD
Bosentan—Nausea—Vinorelbine—lung cancer	9.66e-05	0.000348	CcSEcCtD
Bosentan—Gastrointestinal disorder—Etoposide—lung cancer	9.63e-05	0.000347	CcSEcCtD
Bosentan—Dyspepsia—Paclitaxel—lung cancer	9.63e-05	0.000347	CcSEcCtD
Bosentan—Body temperature increased—Cisplatin—lung cancer	9.63e-05	0.000347	CcSEcCtD
Bosentan—Asthenia—Irinotecan—lung cancer	9.63e-05	0.000347	CcSEcCtD
Bosentan—Fatigue—Etoposide—lung cancer	9.62e-05	0.000347	CcSEcCtD
Bosentan—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—lung cancer	9.61e-05	0.000346	CcSEcCtD
Bosentan—Pain—Etoposide—lung cancer	9.54e-05	0.000344	CcSEcCtD
Bosentan—Constipation—Etoposide—lung cancer	9.54e-05	0.000344	CcSEcCtD
Bosentan—Neutropenia—Doxorubicin—lung cancer	9.52e-05	0.000343	CcSEcCtD
Bosentan—Dysuria—Doxorubicin—lung cancer	9.52e-05	0.000343	CcSEcCtD
Bosentan—Decreased appetite—Paclitaxel—lung cancer	9.51e-05	0.000343	CcSEcCtD
Bosentan—Dry mouth—Docetaxel—lung cancer	9.46e-05	0.000341	CcSEcCtD
Bosentan—Upper respiratory tract infection—Doxorubicin—lung cancer	9.46e-05	0.000341	CcSEcCtD
Bosentan—Haemoglobin—Methotrexate—lung cancer	9.46e-05	0.000341	CcSEcCtD
Bosentan—Gastrointestinal disorder—Paclitaxel—lung cancer	9.45e-05	0.000341	CcSEcCtD
Bosentan—Fatigue—Paclitaxel—lung cancer	9.43e-05	0.00034	CcSEcCtD
Bosentan—Haemorrhage—Methotrexate—lung cancer	9.41e-05	0.000339	CcSEcCtD
Bosentan—Hepatitis—Methotrexate—lung cancer	9.41e-05	0.000339	CcSEcCtD
Bosentan—Pollakiuria—Doxorubicin—lung cancer	9.4e-05	0.000339	CcSEcCtD
Bosentan—Asthenia—Gemcitabine—lung cancer	9.38e-05	0.000338	CcSEcCtD
Bosentan—Constipation—Paclitaxel—lung cancer	9.36e-05	0.000337	CcSEcCtD
Bosentan—Pain—Paclitaxel—lung cancer	9.36e-05	0.000337	CcSEcCtD
Bosentan—Urinary tract disorder—Methotrexate—lung cancer	9.29e-05	0.000335	CcSEcCtD
Bosentan—Oedema—Docetaxel—lung cancer	9.27e-05	0.000334	CcSEcCtD
Bosentan—Anaphylactic shock—Docetaxel—lung cancer	9.27e-05	0.000334	CcSEcCtD
Bosentan—Weight increased—Doxorubicin—lung cancer	9.26e-05	0.000334	CcSEcCtD
Bosentan—Pruritus—Gemcitabine—lung cancer	9.25e-05	0.000333	CcSEcCtD
Bosentan—Urethral disorder—Methotrexate—lung cancer	9.22e-05	0.000333	CcSEcCtD
Bosentan—Infection—Docetaxel—lung cancer	9.21e-05	0.000332	CcSEcCtD
Bosentan—Weight decreased—Doxorubicin—lung cancer	9.21e-05	0.000332	CcSEcCtD
Bosentan—Hyperglycaemia—Doxorubicin—lung cancer	9.18e-05	0.000331	CcSEcCtD
Bosentan—Diarrhoea—Irinotecan—lung cancer	9.18e-05	0.000331	CcSEcCtD
Bosentan—Pneumonia—Doxorubicin—lung cancer	9.13e-05	0.000329	CcSEcCtD
Bosentan—Gastrointestinal pain—Etoposide—lung cancer	9.13e-05	0.000329	CcSEcCtD
Bosentan—Shock—Docetaxel—lung cancer	9.12e-05	0.000329	CcSEcCtD
Bosentan—Nervous system disorder—Docetaxel—lung cancer	9.1e-05	0.000328	CcSEcCtD
Bosentan—Thrombocytopenia—Docetaxel—lung cancer	9.08e-05	0.000327	CcSEcCtD
Bosentan—Infestation NOS—Doxorubicin—lung cancer	9.08e-05	0.000327	CcSEcCtD
Bosentan—Infestation—Doxorubicin—lung cancer	9.08e-05	0.000327	CcSEcCtD
Bosentan—Tachycardia—Docetaxel—lung cancer	9.05e-05	0.000326	CcSEcCtD
Bosentan—Skin disorder—Docetaxel—lung cancer	9.01e-05	0.000325	CcSEcCtD
Bosentan—Stevens-Johnson syndrome—Doxorubicin—lung cancer	9e-05	0.000324	CcSEcCtD
Bosentan—Hypersensitivity—Cisplatin—lung cancer	8.97e-05	0.000324	CcSEcCtD
Bosentan—Gastrointestinal pain—Paclitaxel—lung cancer	8.95e-05	0.000323	CcSEcCtD
Bosentan—Diarrhoea—Gemcitabine—lung cancer	8.94e-05	0.000322	CcSEcCtD
Bosentan—Renal failure—Doxorubicin—lung cancer	8.92e-05	0.000322	CcSEcCtD
Bosentan—Erythema multiforme—Methotrexate—lung cancer	8.9e-05	0.000321	CcSEcCtD
Bosentan—Dizziness—Irinotecan—lung cancer	8.87e-05	0.00032	CcSEcCtD
Bosentan—Urticaria—Etoposide—lung cancer	8.87e-05	0.00032	CcSEcCtD
Bosentan—Stomatitis—Doxorubicin—lung cancer	8.85e-05	0.000319	CcSEcCtD
Bosentan—Jaundice—Doxorubicin—lung cancer	8.85e-05	0.000319	CcSEcCtD
Bosentan—Anorexia—Docetaxel—lung cancer	8.84e-05	0.000319	CcSEcCtD
Bosentan—Abdominal pain—Etoposide—lung cancer	8.82e-05	0.000318	CcSEcCtD
Bosentan—Body temperature increased—Etoposide—lung cancer	8.82e-05	0.000318	CcSEcCtD
Bosentan—Urinary tract infection—Doxorubicin—lung cancer	8.82e-05	0.000318	CcSEcCtD
Bosentan—Conjunctivitis—Doxorubicin—lung cancer	8.82e-05	0.000318	CcSEcCtD
Bosentan—Eye disorder—Methotrexate—lung cancer	8.79e-05	0.000317	CcSEcCtD
Bosentan—Tinnitus—Methotrexate—lung cancer	8.77e-05	0.000316	CcSEcCtD
Bosentan—Asthenia—Cisplatin—lung cancer	8.74e-05	0.000315	CcSEcCtD
Bosentan—Cardiac disorder—Methotrexate—lung cancer	8.73e-05	0.000315	CcSEcCtD
Bosentan—Urticaria—Paclitaxel—lung cancer	8.69e-05	0.000313	CcSEcCtD
Bosentan—Hypotension—Docetaxel—lung cancer	8.67e-05	0.000312	CcSEcCtD
Bosentan—Haematuria—Doxorubicin—lung cancer	8.65e-05	0.000312	CcSEcCtD
Bosentan—Abdominal pain—Paclitaxel—lung cancer	8.65e-05	0.000312	CcSEcCtD
Bosentan—Body temperature increased—Paclitaxel—lung cancer	8.65e-05	0.000312	CcSEcCtD
Bosentan—Hepatobiliary disease—Doxorubicin—lung cancer	8.58e-05	0.000309	CcSEcCtD
Bosentan—Epistaxis—Doxorubicin—lung cancer	8.56e-05	0.000309	CcSEcCtD
Bosentan—Angiopathy—Methotrexate—lung cancer	8.54e-05	0.000308	CcSEcCtD
Bosentan—Vomiting—Irinotecan—lung cancer	8.53e-05	0.000308	CcSEcCtD
Bosentan—Sinusitis—Doxorubicin—lung cancer	8.51e-05	0.000307	CcSEcCtD
Bosentan—Immune system disorder—Methotrexate—lung cancer	8.5e-05	0.000306	CcSEcCtD
Bosentan—Mediastinal disorder—Methotrexate—lung cancer	8.48e-05	0.000306	CcSEcCtD
Bosentan—Rash—Irinotecan—lung cancer	8.46e-05	0.000305	CcSEcCtD
Bosentan—Dermatitis—Irinotecan—lung cancer	8.45e-05	0.000305	CcSEcCtD
Bosentan—Musculoskeletal discomfort—Docetaxel—lung cancer	8.45e-05	0.000305	CcSEcCtD
Bosentan—Chills—Methotrexate—lung cancer	8.44e-05	0.000304	CcSEcCtD
Bosentan—Headache—Irinotecan—lung cancer	8.41e-05	0.000303	CcSEcCtD
Bosentan—Insomnia—Docetaxel—lung cancer	8.39e-05	0.000302	CcSEcCtD
Bosentan—Diarrhoea—Cisplatin—lung cancer	8.33e-05	0.000301	CcSEcCtD
Bosentan—Paraesthesia—Docetaxel—lung cancer	8.33e-05	0.0003	CcSEcCtD
Bosentan—Vomiting—Gemcitabine—lung cancer	8.31e-05	0.0003	CcSEcCtD
Bosentan—Bradycardia—Doxorubicin—lung cancer	8.29e-05	0.000299	CcSEcCtD
Bosentan—Dyspnoea—Docetaxel—lung cancer	8.27e-05	0.000298	CcSEcCtD
Bosentan—Somnolence—Docetaxel—lung cancer	8.25e-05	0.000297	CcSEcCtD
Bosentan—Mental disorder—Methotrexate—lung cancer	8.24e-05	0.000297	CcSEcCtD
Bosentan—Rash—Gemcitabine—lung cancer	8.24e-05	0.000297	CcSEcCtD
Bosentan—Dermatitis—Gemcitabine—lung cancer	8.23e-05	0.000297	CcSEcCtD
Bosentan—Hypersensitivity—Etoposide—lung cancer	8.22e-05	0.000296	CcSEcCtD
Bosentan—Erythema—Methotrexate—lung cancer	8.19e-05	0.000295	CcSEcCtD
Bosentan—Malnutrition—Methotrexate—lung cancer	8.19e-05	0.000295	CcSEcCtD
Bosentan—Haemoglobin—Doxorubicin—lung cancer	8.19e-05	0.000295	CcSEcCtD
Bosentan—Headache—Gemcitabine—lung cancer	8.19e-05	0.000295	CcSEcCtD
Bosentan—Dyspepsia—Docetaxel—lung cancer	8.16e-05	0.000294	CcSEcCtD
Bosentan—Hepatitis—Doxorubicin—lung cancer	8.15e-05	0.000294	CcSEcCtD
Bosentan—Haemorrhage—Doxorubicin—lung cancer	8.15e-05	0.000294	CcSEcCtD
Bosentan—Hypoaesthesia—Doxorubicin—lung cancer	8.11e-05	0.000292	CcSEcCtD
Bosentan—Decreased appetite—Docetaxel—lung cancer	8.06e-05	0.000291	CcSEcCtD
Bosentan—Hypersensitivity—Paclitaxel—lung cancer	8.06e-05	0.000291	CcSEcCtD
Bosentan—Urinary tract disorder—Doxorubicin—lung cancer	8.05e-05	0.00029	CcSEcCtD
Bosentan—Oedema peripheral—Doxorubicin—lung cancer	8.03e-05	0.000289	CcSEcCtD
Bosentan—Gastrointestinal disorder—Docetaxel—lung cancer	8.01e-05	0.000289	CcSEcCtD
Bosentan—Asthenia—Etoposide—lung cancer	8.01e-05	0.000289	CcSEcCtD
Bosentan—Fatigue—Docetaxel—lung cancer	8e-05	0.000288	CcSEcCtD
Bosentan—Urethral disorder—Doxorubicin—lung cancer	7.99e-05	0.000288	CcSEcCtD
Bosentan—Nausea—Irinotecan—lung cancer	7.97e-05	0.000287	CcSEcCtD
Bosentan—Pain—Docetaxel—lung cancer	7.93e-05	0.000286	CcSEcCtD
Bosentan—Constipation—Docetaxel—lung cancer	7.93e-05	0.000286	CcSEcCtD
Bosentan—Back pain—Methotrexate—lung cancer	7.92e-05	0.000286	CcSEcCtD
Bosentan—Pruritus—Etoposide—lung cancer	7.9e-05	0.000285	CcSEcCtD
Bosentan—Asthenia—Paclitaxel—lung cancer	7.85e-05	0.000283	CcSEcCtD
Bosentan—Nausea—Gemcitabine—lung cancer	7.76e-05	0.00028	CcSEcCtD
Bosentan—Vomiting—Cisplatin—lung cancer	7.75e-05	0.000279	CcSEcCtD
Bosentan—Pruritus—Paclitaxel—lung cancer	7.74e-05	0.000279	CcSEcCtD
Bosentan—Vision blurred—Methotrexate—lung cancer	7.72e-05	0.000278	CcSEcCtD
Bosentan—Erythema multiforme—Doxorubicin—lung cancer	7.7e-05	0.000278	CcSEcCtD
Bosentan—Rash—Cisplatin—lung cancer	7.68e-05	0.000277	CcSEcCtD
Bosentan—Dermatitis—Cisplatin—lung cancer	7.67e-05	0.000277	CcSEcCtD
Bosentan—Diarrhoea—Etoposide—lung cancer	7.64e-05	0.000275	CcSEcCtD
Bosentan—Eye disorder—Doxorubicin—lung cancer	7.61e-05	0.000275	CcSEcCtD
Bosentan—Tinnitus—Doxorubicin—lung cancer	7.6e-05	0.000274	CcSEcCtD
Bosentan—Gastrointestinal pain—Docetaxel—lung cancer	7.58e-05	0.000273	CcSEcCtD
Bosentan—Anaemia—Methotrexate—lung cancer	7.57e-05	0.000273	CcSEcCtD
Bosentan—Cardiac disorder—Doxorubicin—lung cancer	7.56e-05	0.000273	CcSEcCtD
Bosentan—Flushing—Doxorubicin—lung cancer	7.56e-05	0.000273	CcSEcCtD
Bosentan—Diarrhoea—Paclitaxel—lung cancer	7.49e-05	0.00027	CcSEcCtD
Bosentan—Angiopathy—Doxorubicin—lung cancer	7.39e-05	0.000267	CcSEcCtD
Bosentan—Dizziness—Etoposide—lung cancer	7.38e-05	0.000266	CcSEcCtD
Bosentan—Immune system disorder—Doxorubicin—lung cancer	7.36e-05	0.000265	CcSEcCtD
Bosentan—Vertigo—Methotrexate—lung cancer	7.36e-05	0.000265	CcSEcCtD
Bosentan—Mediastinal disorder—Doxorubicin—lung cancer	7.34e-05	0.000265	CcSEcCtD
Bosentan—Body temperature increased—Docetaxel—lung cancer	7.33e-05	0.000264	CcSEcCtD
Bosentan—Abdominal pain—Docetaxel—lung cancer	7.33e-05	0.000264	CcSEcCtD
Bosentan—Leukopenia—Methotrexate—lung cancer	7.33e-05	0.000264	CcSEcCtD
Bosentan—Chills—Doxorubicin—lung cancer	7.31e-05	0.000264	CcSEcCtD
Bosentan—Dizziness—Paclitaxel—lung cancer	7.24e-05	0.000261	CcSEcCtD
Bosentan—Nausea—Cisplatin—lung cancer	7.24e-05	0.000261	CcSEcCtD
Bosentan—Cough—Methotrexate—lung cancer	7.15e-05	0.000258	CcSEcCtD
Bosentan—Mental disorder—Doxorubicin—lung cancer	7.14e-05	0.000257	CcSEcCtD
Bosentan—Vomiting—Etoposide—lung cancer	7.1e-05	0.000256	CcSEcCtD
Bosentan—Erythema—Doxorubicin—lung cancer	7.09e-05	0.000256	CcSEcCtD
Bosentan—Malnutrition—Doxorubicin—lung cancer	7.09e-05	0.000256	CcSEcCtD
Bosentan—Rash—Etoposide—lung cancer	7.04e-05	0.000254	CcSEcCtD
Bosentan—Dermatitis—Etoposide—lung cancer	7.03e-05	0.000253	CcSEcCtD
Bosentan—Headache—Etoposide—lung cancer	6.99e-05	0.000252	CcSEcCtD
Bosentan—Flatulence—Doxorubicin—lung cancer	6.99e-05	0.000252	CcSEcCtD
Bosentan—Chest pain—Methotrexate—lung cancer	6.97e-05	0.000251	CcSEcCtD
Bosentan—Arthralgia—Methotrexate—lung cancer	6.97e-05	0.000251	CcSEcCtD
Bosentan—Vomiting—Paclitaxel—lung cancer	6.96e-05	0.000251	CcSEcCtD
Bosentan—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—lung cancer	6.93e-05	0.00025	CcSEcCtD
Bosentan—Rash—Paclitaxel—lung cancer	6.9e-05	0.000249	CcSEcCtD
Bosentan—Dermatitis—Paclitaxel—lung cancer	6.89e-05	0.000249	CcSEcCtD
Bosentan—Discomfort—Methotrexate—lung cancer	6.89e-05	0.000248	CcSEcCtD
Bosentan—Back pain—Doxorubicin—lung cancer	6.86e-05	0.000247	CcSEcCtD
Bosentan—Headache—Paclitaxel—lung cancer	6.85e-05	0.000247	CcSEcCtD
Bosentan—Hypersensitivity—Docetaxel—lung cancer	6.83e-05	0.000246	CcSEcCtD
Bosentan—Muscle spasms—Doxorubicin—lung cancer	6.82e-05	0.000246	CcSEcCtD
Bosentan—Anaphylactic shock—Methotrexate—lung cancer	6.68e-05	0.000241	CcSEcCtD
Bosentan—Vision blurred—Doxorubicin—lung cancer	6.68e-05	0.000241	CcSEcCtD
Bosentan—Asthenia—Docetaxel—lung cancer	6.65e-05	0.00024	CcSEcCtD
Bosentan—Infection—Methotrexate—lung cancer	6.64e-05	0.000239	CcSEcCtD
Bosentan—Nausea—Etoposide—lung cancer	6.63e-05	0.000239	CcSEcCtD
Bosentan—Pruritus—Docetaxel—lung cancer	6.56e-05	0.000237	CcSEcCtD
Bosentan—Nervous system disorder—Methotrexate—lung cancer	6.56e-05	0.000236	CcSEcCtD
Bosentan—Anaemia—Doxorubicin—lung cancer	6.56e-05	0.000236	CcSEcCtD
Bosentan—Thrombocytopenia—Methotrexate—lung cancer	6.54e-05	0.000236	CcSEcCtD
Bosentan—Nausea—Paclitaxel—lung cancer	6.5e-05	0.000234	CcSEcCtD
Bosentan—Skin disorder—Methotrexate—lung cancer	6.49e-05	0.000234	CcSEcCtD
Bosentan—Hyperhidrosis—Methotrexate—lung cancer	6.46e-05	0.000233	CcSEcCtD
Bosentan—Vertigo—Doxorubicin—lung cancer	6.37e-05	0.00023	CcSEcCtD
Bosentan—Anorexia—Methotrexate—lung cancer	6.37e-05	0.00023	CcSEcCtD
Bosentan—Syncope—Doxorubicin—lung cancer	6.36e-05	0.000229	CcSEcCtD
Bosentan—Leukopenia—Doxorubicin—lung cancer	6.35e-05	0.000229	CcSEcCtD
Bosentan—Diarrhoea—Docetaxel—lung cancer	6.35e-05	0.000229	CcSEcCtD
Bosentan—Palpitations—Doxorubicin—lung cancer	6.27e-05	0.000226	CcSEcCtD
Bosentan—Hypotension—Methotrexate—lung cancer	6.25e-05	0.000225	CcSEcCtD
Bosentan—Loss of consciousness—Doxorubicin—lung cancer	6.23e-05	0.000225	CcSEcCtD
Bosentan—Cough—Doxorubicin—lung cancer	6.19e-05	0.000223	CcSEcCtD
Bosentan—Dizziness—Docetaxel—lung cancer	6.13e-05	0.000221	CcSEcCtD
Bosentan—Musculoskeletal discomfort—Methotrexate—lung cancer	6.09e-05	0.00022	CcSEcCtD
Bosentan—Insomnia—Methotrexate—lung cancer	6.05e-05	0.000218	CcSEcCtD
Bosentan—Chest pain—Doxorubicin—lung cancer	6.04e-05	0.000218	CcSEcCtD
Bosentan—Arthralgia—Doxorubicin—lung cancer	6.04e-05	0.000218	CcSEcCtD
Bosentan—Anxiety—Doxorubicin—lung cancer	6.02e-05	0.000217	CcSEcCtD
Bosentan—Paraesthesia—Methotrexate—lung cancer	6e-05	0.000216	CcSEcCtD
Bosentan—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—lung cancer	6e-05	0.000216	CcSEcCtD
Bosentan—Discomfort—Doxorubicin—lung cancer	5.97e-05	0.000215	CcSEcCtD
Bosentan—Dyspnoea—Methotrexate—lung cancer	5.96e-05	0.000215	CcSEcCtD
Bosentan—Somnolence—Methotrexate—lung cancer	5.94e-05	0.000214	CcSEcCtD
Bosentan—Dry mouth—Doxorubicin—lung cancer	5.91e-05	0.000213	CcSEcCtD
Bosentan—Vomiting—Docetaxel—lung cancer	5.9e-05	0.000213	CcSEcCtD
Bosentan—Dyspepsia—Methotrexate—lung cancer	5.88e-05	0.000212	CcSEcCtD
Bosentan—Rash—Docetaxel—lung cancer	5.85e-05	0.000211	CcSEcCtD
Bosentan—Dermatitis—Docetaxel—lung cancer	5.84e-05	0.000211	CcSEcCtD
Bosentan—Decreased appetite—Methotrexate—lung cancer	5.81e-05	0.00021	CcSEcCtD
Bosentan—Headache—Docetaxel—lung cancer	5.81e-05	0.000209	CcSEcCtD
Bosentan—Oedema—Doxorubicin—lung cancer	5.79e-05	0.000209	CcSEcCtD
Bosentan—Anaphylactic shock—Doxorubicin—lung cancer	5.79e-05	0.000209	CcSEcCtD
Bosentan—Gastrointestinal disorder—Methotrexate—lung cancer	5.77e-05	0.000208	CcSEcCtD
Bosentan—Fatigue—Methotrexate—lung cancer	5.76e-05	0.000208	CcSEcCtD
Bosentan—Infection—Doxorubicin—lung cancer	5.75e-05	0.000207	CcSEcCtD
Bosentan—Pain—Methotrexate—lung cancer	5.72e-05	0.000206	CcSEcCtD
Bosentan—Shock—Doxorubicin—lung cancer	5.69e-05	0.000205	CcSEcCtD
Bosentan—Nervous system disorder—Doxorubicin—lung cancer	5.68e-05	0.000205	CcSEcCtD
Bosentan—Thrombocytopenia—Doxorubicin—lung cancer	5.67e-05	0.000204	CcSEcCtD
Bosentan—Tachycardia—Doxorubicin—lung cancer	5.65e-05	0.000204	CcSEcCtD
Bosentan—Skin disorder—Doxorubicin—lung cancer	5.62e-05	0.000203	CcSEcCtD
Bosentan—Hyperhidrosis—Doxorubicin—lung cancer	5.6e-05	0.000202	CcSEcCtD
Bosentan—Anorexia—Doxorubicin—lung cancer	5.52e-05	0.000199	CcSEcCtD
Bosentan—Nausea—Docetaxel—lung cancer	5.51e-05	0.000199	CcSEcCtD
Bosentan—Gastrointestinal pain—Methotrexate—lung cancer	5.47e-05	0.000197	CcSEcCtD
Bosentan—Hypotension—Doxorubicin—lung cancer	5.41e-05	0.000195	CcSEcCtD
Bosentan—Urticaria—Methotrexate—lung cancer	5.31e-05	0.000191	CcSEcCtD
Bosentan—Abdominal pain—Methotrexate—lung cancer	5.28e-05	0.000191	CcSEcCtD
Bosentan—Body temperature increased—Methotrexate—lung cancer	5.28e-05	0.000191	CcSEcCtD
Bosentan—Musculoskeletal discomfort—Doxorubicin—lung cancer	5.27e-05	0.00019	CcSEcCtD
Bosentan—Insomnia—Doxorubicin—lung cancer	5.24e-05	0.000189	CcSEcCtD
Bosentan—Paraesthesia—Doxorubicin—lung cancer	5.2e-05	0.000187	CcSEcCtD
Bosentan—Dyspnoea—Doxorubicin—lung cancer	5.16e-05	0.000186	CcSEcCtD
Bosentan—Somnolence—Doxorubicin—lung cancer	5.15e-05	0.000186	CcSEcCtD
Bosentan—Dyspepsia—Doxorubicin—lung cancer	5.1e-05	0.000184	CcSEcCtD
Bosentan—Decreased appetite—Doxorubicin—lung cancer	5.03e-05	0.000181	CcSEcCtD
Bosentan—Gastrointestinal disorder—Doxorubicin—lung cancer	5e-05	0.00018	CcSEcCtD
Bosentan—Fatigue—Doxorubicin—lung cancer	4.99e-05	0.00018	CcSEcCtD
Bosentan—Constipation—Doxorubicin—lung cancer	4.95e-05	0.000178	CcSEcCtD
Bosentan—Pain—Doxorubicin—lung cancer	4.95e-05	0.000178	CcSEcCtD
Bosentan—Hypersensitivity—Methotrexate—lung cancer	4.92e-05	0.000178	CcSEcCtD
Bosentan—Asthenia—Methotrexate—lung cancer	4.8e-05	0.000173	CcSEcCtD
Bosentan—Gastrointestinal pain—Doxorubicin—lung cancer	4.73e-05	0.000171	CcSEcCtD
Bosentan—Pruritus—Methotrexate—lung cancer	4.73e-05	0.000171	CcSEcCtD
Bosentan—Urticaria—Doxorubicin—lung cancer	4.6e-05	0.000166	CcSEcCtD
Bosentan—Abdominal pain—Doxorubicin—lung cancer	4.58e-05	0.000165	CcSEcCtD
Bosentan—Body temperature increased—Doxorubicin—lung cancer	4.58e-05	0.000165	CcSEcCtD
Bosentan—Diarrhoea—Methotrexate—lung cancer	4.57e-05	0.000165	CcSEcCtD
Bosentan—Dizziness—Methotrexate—lung cancer	4.42e-05	0.000159	CcSEcCtD
Bosentan—Hypersensitivity—Doxorubicin—lung cancer	4.26e-05	0.000154	CcSEcCtD
Bosentan—Vomiting—Methotrexate—lung cancer	4.25e-05	0.000153	CcSEcCtD
Bosentan—Rash—Methotrexate—lung cancer	4.21e-05	0.000152	CcSEcCtD
Bosentan—Dermatitis—Methotrexate—lung cancer	4.21e-05	0.000152	CcSEcCtD
Bosentan—Headache—Methotrexate—lung cancer	4.19e-05	0.000151	CcSEcCtD
Bosentan—Asthenia—Doxorubicin—lung cancer	4.15e-05	0.00015	CcSEcCtD
Bosentan—Pruritus—Doxorubicin—lung cancer	4.1e-05	0.000148	CcSEcCtD
Bosentan—Nausea—Methotrexate—lung cancer	3.97e-05	0.000143	CcSEcCtD
Bosentan—Diarrhoea—Doxorubicin—lung cancer	3.96e-05	0.000143	CcSEcCtD
Bosentan—Dizziness—Doxorubicin—lung cancer	3.83e-05	0.000138	CcSEcCtD
Bosentan—Vomiting—Doxorubicin—lung cancer	3.68e-05	0.000133	CcSEcCtD
Bosentan—Rash—Doxorubicin—lung cancer	3.65e-05	0.000132	CcSEcCtD
Bosentan—Dermatitis—Doxorubicin—lung cancer	3.65e-05	0.000131	CcSEcCtD
Bosentan—Headache—Doxorubicin—lung cancer	3.63e-05	0.000131	CcSEcCtD
Bosentan—Nausea—Doxorubicin—lung cancer	3.44e-05	0.000124	CcSEcCtD
Bosentan—CYP3A4—Biological oxidations—GSTM1—lung cancer	3.39e-05	0.000278	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—POMC—lung cancer	3.37e-05	0.000277	CbGpPWpGaD
Bosentan—EDNRA—Signaling by GPCR—RAF1—lung cancer	3.37e-05	0.000277	CbGpPWpGaD
Bosentan—ABCB11—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	3.36e-05	0.000276	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism of lipids and lipoproteins—NCOA3—lung cancer	3.35e-05	0.000275	CbGpPWpGaD
Bosentan—CYP3A4—Metapathway biotransformation—GSTM1—lung cancer	3.34e-05	0.000275	CbGpPWpGaD
Bosentan—ABCB11—Metabolism of lipids and lipoproteins—PTGS2—lung cancer	3.33e-05	0.000274	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—BRAF—lung cancer	3.33e-05	0.000274	CbGpPWpGaD
Bosentan—EDNRA—GPCR downstream signaling—IL2—lung cancer	3.33e-05	0.000273	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—IL6R—lung cancer	3.29e-05	0.00027	CbGpPWpGaD
Bosentan—EDNRA—Signaling by GPCR—PIK3CB—lung cancer	3.29e-05	0.00027	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—CREBBP—lung cancer	3.29e-05	0.00027	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—PLBD1—lung cancer	3.25e-05	0.000267	CbGpPWpGaD
Bosentan—EDNRB—Signaling by GPCR—EGFR—lung cancer	3.23e-05	0.000265	CbGpPWpGaD
Bosentan—CYP3A4—Biological oxidations—CYP1A1—lung cancer	3.21e-05	0.000264	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism of lipids and lipoproteins—HPGDS—lung cancer	3.19e-05	0.000262	CbGpPWpGaD
Bosentan—CYP3A4—Metapathway biotransformation—CYP1A1—lung cancer	3.17e-05	0.00026	CbGpPWpGaD
Bosentan—EDNRA—Signaling by GPCR—CXCL8—lung cancer	3.16e-05	0.00026	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—ERBB3—lung cancer	3.14e-05	0.000258	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—MAP2K1—lung cancer	3.14e-05	0.000258	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—PIK3CD—lung cancer	3.12e-05	0.000256	CbGpPWpGaD
Bosentan—ABCB11—Metabolism—STK11—lung cancer	3.1e-05	0.000254	CbGpPWpGaD
Bosentan—EDNRB—GPCR downstream signaling—PIK3CA—lung cancer	3.09e-05	0.000253	CbGpPWpGaD
Bosentan—EDNRB—Signaling by GPCR—KRAS—lung cancer	3.05e-05	0.000251	CbGpPWpGaD
Bosentan—EDNRA—Signaling by GPCR—IL2—lung cancer	3.02e-05	0.000248	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—TERT—lung cancer	3.01e-05	0.000247	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—HSD17B10—lung cancer	2.97e-05	0.000244	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—FGFR1—lung cancer	2.92e-05	0.00024	CbGpPWpGaD
Bosentan—ABCB11—Metabolism of lipids and lipoproteins—PTEN—lung cancer	2.91e-05	0.000239	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—HIF1A—lung cancer	2.88e-05	0.000236	CbGpPWpGaD
Bosentan—ABCB11—Metabolism—GSTP1—lung cancer	2.86e-05	0.000235	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—COL4A3BP—lung cancer	2.83e-05	0.000232	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—AZIN2—lung cancer	2.83e-05	0.000232	CbGpPWpGaD
Bosentan—EDNRB—Signaling by GPCR—PIK3CA—lung cancer	2.8e-05	0.00023	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—MDM2—lung cancer	2.79e-05	0.000229	CbGpPWpGaD
Bosentan—ABCB11—Metabolism—CAT—lung cancer	2.79e-05	0.000229	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—RAF1—lung cancer	2.78e-05	0.000228	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—APOA1—lung cancer	2.78e-05	0.000228	CbGpPWpGaD
Bosentan—ABCB11—Metabolism of lipids and lipoproteins—EP300—lung cancer	2.77e-05	0.000228	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—CKB—lung cancer	2.76e-05	0.000227	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—KDR—lung cancer	2.75e-05	0.000226	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—ERBB2—lung cancer	2.75e-05	0.000226	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—MTOR—lung cancer	2.72e-05	0.000223	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—PIK3CB—lung cancer	2.72e-05	0.000223	CbGpPWpGaD
Bosentan—ABCB11—Metabolism—ABCB1—lung cancer	2.71e-05	0.000223	CbGpPWpGaD
Bosentan—ABCB11—Metabolism—TYMS—lung cancer	2.66e-05	0.000219	CbGpPWpGaD
Bosentan—ABCB11—Metabolism—GSTM1—lung cancer	2.63e-05	0.000216	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—CXCL8—lung cancer	2.61e-05	0.000214	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—CNDP2—lung cancer	2.6e-05	0.000213	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—GSTM2—lung cancer	2.6e-05	0.000213	CbGpPWpGaD
Bosentan—EDNRB—Signaling by GPCR—HRAS—lung cancer	2.59e-05	0.000213	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—PIK3CG—lung cancer	2.54e-05	0.000208	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—APC—lung cancer	2.54e-05	0.000208	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—KIT—lung cancer	2.54e-05	0.000208	CbGpPWpGaD
Bosentan—EDNRA—Signaling by GPCR—NRAS—lung cancer	2.54e-05	0.000208	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—MTMR3—lung cancer	2.53e-05	0.000207	CbGpPWpGaD
Bosentan—EDNRB—GPCR downstream signaling—AKT1—lung cancer	2.52e-05	0.000207	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—EGF—lung cancer	2.51e-05	0.000206	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—CASP3—lung cancer	2.5e-05	0.000205	CbGpPWpGaD
Bosentan—ABCB11—Metabolism—CYP1A1—lung cancer	2.5e-05	0.000205	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—IL2—lung cancer	2.49e-05	0.000205	CbGpPWpGaD
Bosentan—EDNRB—Signaling by GPCR—IL6—lung cancer	2.48e-05	0.000204	CbGpPWpGaD
Bosentan—ABCB11—Metabolism—ERCC2—lung cancer	2.47e-05	0.000203	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—PGAM1—lung cancer	2.46e-05	0.000202	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—CCND1—lung cancer	2.43e-05	0.0002	CbGpPWpGaD
Bosentan—EDNRA—Signaling by GPCR—MAPK3—lung cancer	2.43e-05	0.0002	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—JUN—lung cancer	2.43e-05	0.000199	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—POMC—lung cancer	2.41e-05	0.000198	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—ATP5H—lung cancer	2.4e-05	0.000197	CbGpPWpGaD
Bosentan—CYP3A4—Biological oxidations—POMC—lung cancer	2.4e-05	0.000197	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—BRAF—lung cancer	2.38e-05	0.000196	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—MMP9—lung cancer	2.36e-05	0.000194	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—IL6R—lung cancer	2.35e-05	0.000193	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—CDKN1A—lung cancer	2.35e-05	0.000193	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—CREBBP—lung cancer	2.35e-05	0.000193	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—CYP2A7—lung cancer	2.35e-05	0.000193	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—PTEN—lung cancer	2.35e-05	0.000193	CbGpPWpGaD
Bosentan—EDNRA—Signaling by GPCR—EGFR—lung cancer	2.31e-05	0.00019	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—SDC4—lung cancer	2.3e-05	0.000189	CbGpPWpGaD
Bosentan—EDNRB—Signaling by GPCR—AKT1—lung cancer	2.29e-05	0.000188	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—MAP2K1—lung cancer	2.24e-05	0.000184	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—EP300—lung cancer	2.24e-05	0.000184	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—PIK3CD—lung cancer	2.23e-05	0.000183	CbGpPWpGaD
Bosentan—EDNRA—GPCR downstream signaling—PIK3CA—lung cancer	2.21e-05	0.000181	CbGpPWpGaD
Bosentan—EDNRA—Signaling by GPCR—KRAS—lung cancer	2.18e-05	0.000179	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—SRC—lung cancer	2.18e-05	0.000179	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—PLBD1—lung cancer	2.14e-05	0.000176	CbGpPWpGaD
Bosentan—ABCB11—Metabolism—APOA1—lung cancer	2.14e-05	0.000176	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—VEGFA—lung cancer	2.12e-05	0.000174	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—STAT3—lung cancer	2.1e-05	0.000172	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—NRAS—lung cancer	2.09e-05	0.000172	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—RRM1—lung cancer	2.09e-05	0.000172	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—GSTA3—lung cancer	2.09e-05	0.000172	CbGpPWpGaD
Bosentan—ABCB11—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	2.05e-05	0.000168	CbGpPWpGaD
Bosentan—EDNRA—Signaling by GPCR—PIK3CA—lung cancer	2.01e-05	0.000165	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—MAPK3—lung cancer	2e-05	0.000165	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—MDM2—lung cancer	2e-05	0.000164	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—RAF1—lung cancer	1.99e-05	0.000163	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—ERBB2—lung cancer	1.97e-05	0.000162	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—B4GALT5—lung cancer	1.97e-05	0.000162	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—HSD17B10—lung cancer	1.96e-05	0.000161	CbGpPWpGaD
Bosentan—ABCB11—Metabolism—PIK3CG—lung cancer	1.95e-05	0.000161	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—MYC—lung cancer	1.95e-05	0.00016	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—PIK3CB—lung cancer	1.94e-05	0.00016	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—MTOR—lung cancer	1.94e-05	0.00016	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—GSTA4—lung cancer	1.91e-05	0.000157	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—EGFR—lung cancer	1.91e-05	0.000157	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—lung cancer	1.87e-05	0.000154	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—CXCL8—lung cancer	1.87e-05	0.000153	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—GSTA2—lung cancer	1.87e-05	0.000153	CbGpPWpGaD
Bosentan—ABCB11—Metabolism—POMC—lung cancer	1.86e-05	0.000153	CbGpPWpGaD
Bosentan—EDNRA—Signaling by GPCR—HRAS—lung cancer	1.86e-05	0.000152	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—CKB—lung cancer	1.82e-05	0.00015	CbGpPWpGaD
Bosentan—ABCB11—Metabolism—CREBBP—lung cancer	1.81e-05	0.000149	CbGpPWpGaD
Bosentan—EDNRA—GPCR downstream signaling—AKT1—lung cancer	1.8e-05	0.000148	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—KRAS—lung cancer	1.8e-05	0.000148	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—GSTA1—lung cancer	1.8e-05	0.000148	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—CASP3—lung cancer	1.79e-05	0.000147	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—IL2—lung cancer	1.78e-05	0.000147	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—ABCC3—lung cancer	1.78e-05	0.000146	CbGpPWpGaD
Bosentan—EDNRA—Signaling by GPCR—IL6—lung cancer	1.78e-05	0.000146	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—CCND1—lung cancer	1.74e-05	0.000143	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—JUN—lung cancer	1.74e-05	0.000143	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—AKR1C1—lung cancer	1.72e-05	0.000142	CbGpPWpGaD
Bosentan—ABCB11—Metabolism—PIK3CD—lung cancer	1.72e-05	0.000141	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—CNDP2—lung cancer	1.71e-05	0.000141	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—GSTM2—lung cancer	1.71e-05	0.000141	CbGpPWpGaD
Bosentan—ABCB11—Metabolism—ALB—lung cancer	1.7e-05	0.000139	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—MMP9—lung cancer	1.69e-05	0.000139	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—CDKN1A—lung cancer	1.68e-05	0.000138	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—PTEN—lung cancer	1.68e-05	0.000138	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—UGT1A1—lung cancer	1.67e-05	0.000137	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—MTMR3—lung cancer	1.67e-05	0.000137	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—PIK3CA—lung cancer	1.66e-05	0.000136	CbGpPWpGaD
Bosentan—EDNRA—Signaling by GPCR—AKT1—lung cancer	1.64e-05	0.000135	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—PGAM1—lung cancer	1.62e-05	0.000133	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—GNG11—lung cancer	1.61e-05	0.000133	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism of lipids and lipoproteins—APOA1—lung cancer	1.6e-05	0.000132	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—EP300—lung cancer	1.6e-05	0.000132	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—TP53—lung cancer	1.6e-05	0.000132	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—SRC—lung cancer	1.56e-05	0.000128	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—CYP2A7—lung cancer	1.55e-05	0.000127	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—ALDOA—lung cancer	1.54e-05	0.000126	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—HRAS—lung cancer	1.53e-05	0.000126	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—VEGFA—lung cancer	1.52e-05	0.000125	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—SDC4—lung cancer	1.52e-05	0.000124	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—STAT3—lung cancer	1.5e-05	0.000123	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—NRAS—lung cancer	1.5e-05	0.000123	CbGpPWpGaD
Bosentan—ABCB11—Metabolism—PIK3CB—lung cancer	1.5e-05	0.000123	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—NCOA3—lung cancer	1.49e-05	0.000122	CbGpPWpGaD
Bosentan—ABCB11—Metabolism—PTGS2—lung cancer	1.48e-05	0.000122	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—IL6—lung cancer	1.47e-05	0.00012	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—lung cancer	1.47e-05	0.00012	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—ADCY1—lung cancer	1.45e-05	0.000119	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—ABCG2—lung cancer	1.45e-05	0.000119	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—MAPK3—lung cancer	1.43e-05	0.000118	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—ENO2—lung cancer	1.42e-05	0.000117	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—HPGDS—lung cancer	1.42e-05	0.000117	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—PPP2R1B—lung cancer	1.41e-05	0.000116	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—MYC—lung cancer	1.4e-05	0.000115	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism of lipids and lipoproteins—POMC—lung cancer	1.39e-05	0.000115	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—RRM1—lung cancer	1.38e-05	0.000113	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—GSTA3—lung cancer	1.38e-05	0.000113	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—GSTT1—lung cancer	1.38e-05	0.000113	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—EGFR—lung cancer	1.36e-05	0.000112	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—CYP2A6—lung cancer	1.36e-05	0.000112	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—GCLC—lung cancer	1.36e-05	0.000112	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism of lipids and lipoproteins—CREBBP—lung cancer	1.36e-05	0.000112	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—AKT1—lung cancer	1.35e-05	0.000111	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—B4GALT5—lung cancer	1.3e-05	0.000107	CbGpPWpGaD
Bosentan—ABCB11—Metabolism—PTEN—lung cancer	1.29e-05	0.000106	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—ENO1—lung cancer	1.29e-05	0.000106	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—KRAS—lung cancer	1.29e-05	0.000106	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—lung cancer	1.29e-05	0.000106	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism of lipids and lipoproteins—ALB—lung cancer	1.27e-05	0.000104	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—GSTA4—lung cancer	1.26e-05	0.000104	CbGpPWpGaD
Bosentan—ABCB11—Metabolism—EP300—lung cancer	1.23e-05	0.000101	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—GSTA2—lung cancer	1.23e-05	0.000101	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—GSTA1—lung cancer	1.19e-05	9.75e-05	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—PIK3CA—lung cancer	1.18e-05	9.73e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—ABCC3—lung cancer	1.17e-05	9.64e-05	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—CYP2E1—lung cancer	1.16e-05	9.52e-05	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—NQO1—lung cancer	1.15e-05	9.42e-05	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—TP53—lung cancer	1.15e-05	9.41e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—AKR1C1—lung cancer	1.14e-05	9.34e-05	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	1.12e-05	9.22e-05	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—lung cancer	1.11e-05	9.14e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—UGT1A1—lung cancer	1.1e-05	9.06e-05	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—HRAS—lung cancer	1.1e-05	9e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—GNG11—lung cancer	1.06e-05	8.74e-05	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—IL6—lung cancer	1.05e-05	8.62e-05	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—STK11—lung cancer	1.03e-05	8.49e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—ALDOA—lung cancer	1.01e-05	8.32e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—NCOA3—lung cancer	9.83e-06	8.08e-05	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—lung cancer	9.7e-06	7.97e-05	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—AKT1—lung cancer	9.68e-06	7.95e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—ADCY1—lung cancer	9.57e-06	7.86e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—ABCG2—lung cancer	9.57e-06	7.86e-05	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—GSTP1—lung cancer	9.56e-06	7.86e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—HPGDS—lung cancer	9.38e-06	7.71e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—ENO2—lung cancer	9.38e-06	7.71e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—PPP2R1B—lung cancer	9.32e-06	7.66e-05	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—CAT—lung cancer	9.31e-06	7.64e-05	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism of lipids and lipoproteins—EP300—lung cancer	9.25e-06	7.6e-05	CbGpPWpGaD
Bosentan—ABCB11—Metabolism—PIK3CA—lung cancer	9.13e-06	7.5e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—GSTT1—lung cancer	9.1e-06	7.47e-05	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—ABCB1—lung cancer	9.05e-06	7.44e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—GCLC—lung cancer	8.99e-06	7.39e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—CYP2A6—lung cancer	8.99e-06	7.39e-05	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—TYMS—lung cancer	8.89e-06	7.3e-05	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—GSTM1—lung cancer	8.79e-06	7.22e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—ENO1—lung cancer	8.53e-06	7e-05	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—CYP1A1—lung cancer	8.33e-06	6.84e-05	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—ERCC2—lung cancer	8.26e-06	6.79e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—CYP2E1—lung cancer	7.65e-06	6.28e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—NQO1—lung cancer	7.56e-06	6.21e-05	CbGpPWpGaD
Bosentan—ABCB11—Metabolism—AKT1—lung cancer	7.46e-06	6.13e-05	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—APOA1—lung cancer	7.15e-06	5.87e-05	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	6.84e-06	5.62e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—STK11—lung cancer	6.82e-06	5.6e-05	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—PIK3CG—lung cancer	6.53e-06	5.36e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—GSTP1—lung cancer	6.31e-06	5.18e-05	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—POMC—lung cancer	6.21e-06	5.1e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—CAT—lung cancer	6.14e-06	5.04e-05	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—CREBBP—lung cancer	6.05e-06	4.97e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—ABCB1—lung cancer	5.97e-06	4.9e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—TYMS—lung cancer	5.86e-06	4.82e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—GSTM1—lung cancer	5.8e-06	4.76e-05	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—PIK3CD—lung cancer	5.74e-06	4.71e-05	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—ALB—lung cancer	5.66e-06	4.65e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—CYP1A1—lung cancer	5.49e-06	4.51e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—ERCC2—lung cancer	5.45e-06	4.48e-05	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—PIK3CB—lung cancer	5e-06	4.11e-05	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—PTGS2—lung cancer	4.95e-06	4.07e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—APOA1—lung cancer	4.71e-06	3.87e-05	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—PTEN—lung cancer	4.32e-06	3.55e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—PIK3CG—lung cancer	4.3e-06	3.53e-05	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—EP300—lung cancer	4.12e-06	3.38e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—POMC—lung cancer	4.1e-06	3.36e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—CREBBP—lung cancer	3.99e-06	3.28e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—PIK3CD—lung cancer	3.78e-06	3.11e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—ALB—lung cancer	3.73e-06	3.07e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—PIK3CB—lung cancer	3.3e-06	2.71e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—PTGS2—lung cancer	3.27e-06	2.68e-05	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—PIK3CA—lung cancer	3.05e-06	2.5e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—PTEN—lung cancer	2.85e-06	2.34e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—EP300—lung cancer	2.72e-06	2.23e-05	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—AKT1—lung cancer	2.49e-06	2.05e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—PIK3CA—lung cancer	2.01e-06	1.65e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—AKT1—lung cancer	1.64e-06	1.35e-05	CbGpPWpGaD
